2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Poster Session

[P29] Poster Session 29　Lung Cancer/Thoracic Cancer（ICI efficacy 1）

[P29-3] Atezolizumab, bevacizumab, carboplatin, and paclitaxel for advanced NSCLC harboring EGFR mutations after TKI failure

○Yoh Yamaguchi1, Ken Masuda1, Masahiro Torasawa1, Yuki Takeyasu1, Yuki Shinno1, Yuji Matsumoto1, Yusuke Okuma1, Tatsuya Yoshida1,2, Yasushi Goto1, Hidehito Horinouchi1, Noboru Yamamoto1,2, Yuichiro Ohe1 (1.Department of Thoracic Oncology, National Cancer Center Hospital, 2.Department of Experimental Therapeutics, National Cancer Center Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password